Neuroscience
Neuropeptide Y
100%
Cocaine and Amphetamine Regulated Transcript Peptide
89%
Receptor
73%
Behavior (Neuroscience)
64%
Morphine
57%
Spinal Cord Injury
46%
Autoantibodies
40%
Hyperalgesia
34%
Neuroprotective Agent
32%
Nucleus Accumbens Shell
31%
Agmatine
28%
Melanocortin 4 Receptor
28%
Central Nucleus of the Amygdala
28%
Aspartic Acid
28%
Receptor Antibody
28%
Cocaine and Amphetamine Regulated Transcript
28%
Parkinson's Disease
28%
Leucine
28%
Encephalitis
27%
In Vivo
26%
Melanocyte-Stimulating Hormone
26%
In Vitro
25%
Receptor Antagonist
24%
Beta intermedin[11-22][11 (N Acetylcysteine) 14 [3 (2 Naphthyl) Dextro Alanine] 18 Cysteine 22 Aspartic Acid Amide] 11,18 Cyclic Disulfide
23%
Alpha-Melanocyte-Stimulating Hormone
23%
Alzheimer's Disease
21%
Ictal
20%
Amygdala
19%
Neurosteroid
19%
Synaptic Transmission
19%
Ventral Tegmental Area
17%
Electrophysiology
17%
Epileptic Seizure
16%
Arcuate Nucleus
16%
Electrotherapy
15%
Magnetic Resonance Imaging of Brain
15%
Monoclonal Antibody
15%
Medial Forebrain Bundle
15%
Imidazoline Receptor
14%
Allopregnanolone
14%
Serotonergic
14%
Cerebellum
14%
Contactin
14%
Imipramine
14%
Fluoxetine
14%
Nociception
14%
Receptor Protein
14%
Motor Coordination
14%
Olanzapine
14%
L-DOPA
14%
Keyphrases
Cocaine and Amphetamine Regulated Transcript
100%
Neuropeptide Y
87%
Neuropeptide Y Receptor
57%
Morphine
57%
Parkinson's Disease
53%
Seizure
37%
Central Amygdala
37%
Spinal Cord Injury
33%
Autoantibodies
32%
Nucleus Accumbens Shell
32%
Accumbens Shell
30%
Epileptic Seizure
29%
Neuroprotective Effect
28%
Neuropathic Rats
28%
Agmatine
28%
N-methyl-D-aspartate Receptor Antibody
28%
Nicotine
28%
Melanocortin 4 Receptor (MC4R)
28%
Alkyl
28%
Receptor Antagonist
25%
Encephalitis
25%
Autoimmune Encephalitis
22%
Immunoreactivity
22%
Hyperalgesia
21%
Locomotor Recovery
21%
Antibody-mediated
21%
N-methyl-D-aspartate Receptor (NMDAR)
21%
Receptor Agonist
20%
HS014
19%
α-Melanocyte-stimulating Hormone (α-MSH)
19%
Synaptic
19%
Neuropeptide Y System
19%
Spatial Learning
19%
Rodent Models
19%
Spatial Memory
19%
Neurological Disorders
19%
BIBP-3226
18%
Lever Press
18%
Seizure Models
17%
Neurosteroids
17%
Self-stimulation
17%
Arcuate nucleus
17%
Dopamine
16%
Food Intake
16%
Rat Model
15%
Chronic Pain
15%
Monoclonal Antibody
15%
Morphine Withdrawal
15%
Anxiolytic Activity
14%
Obesity
14%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
60%
Diseases
55%
Receptor
55%
Cocaine and Amphetamine Regulated Transcript Peptide
46%
Receptor Antibody
42%
Encephalitis
33%
Hyperalgesia
32%
Spinal Cord Injury
32%
Neuroprotective Agent
32%
Rat Model
28%
Agmatine
28%
Morphine
28%
Table Salt
28%
Neuropeptide Y
28%
Aspartic Acid
28%
Amphetamine
28%
Alzheimer's Disease
25%
Receptor Antagonist
20%
Neurosteroid
19%
Autoantibodies
18%
Imidazoline Receptor
14%
Beta intermedin[11-22][11 (N Acetylcysteine) 14 [3 (2 Naphthyl) Dextro Alanine] 18 Cysteine 22 Aspartic Acid Amide] 11,18 Cyclic Disulfide
14%
Melanocortin 4 Receptor
14%
Polyvinyl Alcohol
14%
Olanzapine
14%
Transdermal Delivery
14%
Antidepressant Activity
14%
Fluoxetine
14%
Imipramine
14%
Hydrogen Sulfide
14%
Levodopa
14%
Trehalose
10%
Methylprednisolone
9%
Pregnenolone Sulfate
9%
Causal Modeling
9%
Neuropathic Pain
7%
Hydrogen Peroxide
7%
Huntington Chorea
7%
Behavioral Neuropharmacology
7%
Peptide Antibody
6%
Allergic Encephalitis
6%
Receptor Agonist
6%
Neuropeptide
5%
Dopamine Receptor Stimulating Agent
5%
Nalpha (Diphenylacetyl) N (4 Hydroxybenzyl) Dextro Argininamide
5%
Antipsychotic
5%